Abbott Laboratories (ABT) Q1 2017 Earnings Results

Abbott Labs Beats on EPS, Stock Up 0.37%

Abbott Labs reported a better-than-expected EPS, which contributed to a slight increase in stock price. The positive surprise in earnings reflects the company's strong performance in specific product lines. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.48	N/A	+11.63%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed confidence in the company's strategic direction. They noted strong performance in certain segments, indicating potential for future growth.

Management highlighted strong performance in key product areas.

They emphasized ongoing investments in innovation.

The team remains focused on long-term growth despite market challenges.

Abbott Labs Beats on EPS, Stock Up 0.37%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Beats on EPS, Stock Up 0.37%

Key numbers

Management commentary